Serum ALT SGPT Liver Test Price in Pakistan at Chughtai Lab

Serum ALT (SGPT) Test at Chughtai Lab

The Serum Alanine Aminotransferase (ALT), historically referred to as Serum Glutamic Pyruvic Transaminase (SGPT), is a fundamental biochemical investigation used to evaluate hepatocyte integrity and overall liver health. Alanine aminotransferase is a homodimeric, pyridoxal phosphate-dependent enzyme primarily localized within the cytosol of hepatocytes. While low concentrations of ALT are physiologically present in skeletal muscle, cardiac tissue, and the kidneys, its concentration within the liver parenchyma is approximately 3,000 times higher than in serum. Consequently, any significant injury to the hepatic cell membrane results in the rapid release of ALT into the systemic circulation, making it an exceptionally sensitive and specific biomarker for hepatocellular damage.

At Chughtai Lab, this diagnostic test is performed using state-of-the-art, fully automated clinical chemistry analyzers. These advanced systems utilize kinetic spectrophotometric assays to measure enzyme activity with high precision and accuracy. The clinical importance of the Serum ALT test lies in its ability to detect early-stage liver injury, often before clinical symptoms such as jaundice, pruritus, or abdominal pain manifest. It serves as a cornerstone of the Liver Function Test (LFT) panel, providing critical diagnostic value for clinicians managing a wide array of metabolic, infectious, toxic, and autoimmune disorders. By quantifying ALT levels, healthcare providers can screen for silent liver conditions, assess the severity of hepatic inflammation, monitor the progression of chronic liver diseases, and evaluate the hepatotoxic potential of various pharmacological agents.

Clinical Procedure: What to Expect

Patient Preparation

Appropriate patient preparation is essential to ensure the clinical accuracy of the Serum ALT (SGPT) test and to minimize the risk of pre-analytical errors. Patients are advised to adhere to the following preparation guidelines:

• Fasting Requirements: While a standalone Serum ALT test does not strictly require fasting, it is frequently ordered alongside a comprehensive Liver Function Test (LFT) panel or a lipid profile. In such cases, a fasting period of 8 to 12 hours is highly recommended. During this time, only plain water is permitted.
• Medication Disclosure: Patients must inform their prescribing physician and the laboratory staff at Chughtai Lab of all medications, over-the-counter drugs, herbal supplements, and vitamins they are currently taking. Certain drugs, including statins, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and antiepileptics, can transiently elevate liver enzymes.
• Avoidance of Alcohol: Consumption of alcohol should be strictly avoided for at least 24 to 48 hours prior to sample collection, as ethanol can induce acute metabolic changes in the liver and alter enzyme levels.
• Physical Activity: Strenuous physical exercise should be avoided for 24 hours before the blood draw, as severe muscle exertion can cause mild elevations in transaminase levels due to muscle cell turnover.
• Hydration: Adequate hydration is encouraged, as it facilitates easier venous access and ensures a smooth venipuncture process.

During the Procedure

The collection of the blood specimen for the Serum ALT (SGPT) test is a routine, minimally invasive phlebotomy procedure performed by trained laboratory professionals at Chughtai Lab. The process involves the following steps:

• Patient Identification and Verification: The phlebotomist verifies the patient’s identity using standard protocols and confirms compliance with any pre-test preparation instructions.
• Positioning: The patient is comfortably seated in a specialized phlebotomy chair, and the arm is extended and supported.
• Site Selection and Preparation: The phlebotomist inspects the antecubital fossa to select a prominent vein, typically the median cubital vein. The skin over the selected site is thoroughly cleansed with a 70% isopropyl alcohol swab using a circular motion and allowed to air dry completely to prevent hemolysis of the sample.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection system is gently inserted into the vein. A gold-top serum separator tube (SST) or a red-top clot activator tube is utilized to collect the blood specimen.
• Tourniquet Management: The tourniquet is applied briefly to engorge the vein but is released within one minute of needle insertion to prevent hemoconcentration.
• Sample Processing: Once the required volume of blood is collected, the needle is withdrawn, and gentle pressure is applied to the puncture site with a sterile gauze pad. A bandage is applied once hemostasis is achieved. The collection tube is gently inverted 5 to 8 times to mix the clot activator with the blood.
• Safety and Comfort: The entire procedure is completed in less than five minutes. Patients may experience a mild, transient pinching sensation at the puncture site, but the risk of complications, such as hematoma or infection, is extremely low when performed under strict aseptic conditions.

When is a Serum ALT (SGPT) Performed?

Evaluation of Unexplained Fatigue and Weakness

Persistent, unexplained fatigue and generalized lethargy are among the most common, albeit non-specific, early indicators of underlying hepatic dysfunction. When the liver’s metabolic and detoxification pathways are compromised due to inflammation or cellular injury, systemic metabolic efficiency declines. Physicians frequently request a Serum ALT (SGPT) test as an initial screening tool to determine whether these constitutional symptoms are linked to subclinical liver disease, such as early-stage viral hepatitis or metabolic dysfunction-associated steatohepatitis.

Assessment of Jaundice and Dark Urine

The development of clinical jaundice, characterized by the yellowing of the sclera and skin, alongside the excretion of dark, tea-colored urine, indicates a significant disruption in bilirubin metabolism or excretion. These symptoms point toward either hepatocellular damage or biliary tract obstruction. An ALT test is crucial in this scenario to differentiate between primary parenchymal liver injury, which typically presents with marked elevations in ALT, and post-hepatic obstructive conditions, where alkaline phosphatase elevations are more pronounced relative to ALT.

Monitoring of Hepatotoxic Medications

Many widely prescribed medications, including lipid-lowering statins, long-term acetaminophen therapy, certain antibiotics, and disease-modifying antirheumatic drugs (DMARDs), carry a risk of drug-induced liver injury (DILI). To ensure patient safety, clinicians perform baseline Serum ALT testing before initiating these therapies, followed by periodic monitoring. A significant rise in ALT levels during treatment serves as an early warning sign, prompting the clinician to adjust the dosage or discontinue the offending drug before irreversible hepatic damage occurs.

Screening for Non-Alcoholic Fatty Liver Disease (NAFLD)

With the rising prevalence of metabolic syndrome, obesity, and type 2 diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD)—recently redefined as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—has become a leading cause of chronic liver disease worldwide. Because early-stage fatty liver is often entirely asymptomatic, routine screening via Serum ALT testing is highly recommended for high-risk individuals. Detecting elevated ALT levels allows for early lifestyle interventions to prevent progression to fibrosis and cirrhosis.

Investigation of Chronic Alcohol Consumption

Chronic and excessive alcohol intake is a well-established cause of liver injury, ranging from simple steatosis to alcoholic hepatitis and cirrhosis. Clinicians utilize the Serum ALT test, often in conjunction with the Aspartate Aminotransferase (AST) test, to evaluate the extent of alcohol-induced hepatocellular damage. Analyzing the ratio of AST to ALT (the De Ritis ratio) provides valuable diagnostic clues, as an AST/ALT ratio greater than 2:1 is highly characteristic of alcoholic liver disease, whereas lower ratios are more common in viral or metabolic etiologies.

What Does a Serum ALT (SGPT) Detect?

The Serum ALT (SGPT) test is a highly sensitive diagnostic tool capable of detecting a wide spectrum of acute and chronic pathological conditions affecting the hepatobiliary system. Specifically, an elevated or abnormal ALT level can indicate the presence of:

• Acute Viral Hepatitis (including Hepatitis A, B, C, D, and E infections)
• Chronic Viral Hepatitis (long-term Hepatitis B or C infection)
• Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
• Non-Alcoholic Steatohepatitis (NASH)
• Alcoholic Liver Disease (including alcoholic steatosis and alcoholic hepatitis)
• Hepatic Cirrhosis (end-stage liver scarring)
• Drug-Induced Liver Injury (DILI) from hepatotoxic medications
• Toxic Hepatitis resulting from exposure to environmental toxins or chemical poisons
• Ischemic Hepatitis (also known as “shock liver” due to profound systemic hypotension)
• Autoimmune Hepatitis (immune-mediated destruction of hepatocytes)
• Hemochromatosis (genetic disorder causing systemic iron overload)
• Wilson’s Disease (congenital disorder of copper metabolism)
• Alpha-1 Antitrypsin Deficiency
• Hepatocellular Carcinoma (primary liver cancer)
• Metastatic Liver Disease (secondary malignancies spreading to the liver)
• Acute Cholecystitis (inflammation of the gallbladder)
• Choledocholithiasis (gallstones obstructing the common bile duct)
• Acute Pancreatitis (severe inflammation of the pancreas)
• Severe Muscle Trauma or Rhabdomyolysis (causing extrahepatic release of ALT)
• Celiac Disease (associated with reactive hepatitis in some patients)
• Congestive Heart Failure (leading to passive hepatic congestion or “cardiac cirrhosis”)

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its commitment to providing rapid, accurate, and highly accessible diagnostic reporting. For a routine blood investigation such as the Serum ALT (SGPT) test, the laboratory utilizes high-throughput automated analyzers that process specimens efficiently. Under normal circumstances, the turnaround time (TAT) for Serum ALT results is within a few hours of sample collection, ensuring that patients and clinicians receive critical data on the same day.

To enhance patient convenience, Chughtai Lab offers multiple digital pathways for accessing diagnostic reports. Once the clinical pathologist verifies and signs off on the results, patients receive an automated SMS notification containing a direct link to download their report. Reports can also be accessed securely through the official Chughtai Lab website portal or via the dedicated Chughtai Lab mobile application. For those who prefer physical copies, reports can be collected directly from any of the numerous Chughtai Lab collection centers located across Pakistan.

Serum ALT (SGPT) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Adult Male ALT Level	10 to 40 U/L	Elevated (>40 U/L) indicating potential hepatocyte damage or inflammation.
Adult Female ALT Level	7 to 35 U/L	Elevated (>35 U/L) indicating potential hepatocyte damage or inflammation.
Mild Elevation (1 to 3x ULN)	N/A	40 to 120 U/L; commonly associated with NAFLD, chronic hepatitis, or early drug-induced liver injury.
Moderate Elevation (3 to 10x ULN)	N/A	120 to 400 U/L; seen in acute biliary obstruction, alcoholic hepatitis, or active autoimmune hepatitis.
Severe Elevation (>10x ULN)	N/A	>400 U/L (often exceeding 1000 U/L); highly indicative of acute viral hepatitis, toxic ingestion, or ischemic shock liver.
ALT to AST Ratio (De Ritis Ratio)	Ratio < 1.0 (in most non-alcoholic liver diseases)	Ratio > 2.0; strongly suggestive of alcoholic liver disease or severe alcoholic hepatitis.
Decreased ALT Levels	N/A	Unusually low levels; occasionally observed in pyridoxal phosphate (Vitamin B6) deficiency or end-stage renal disease.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Serum ALT (SGPT)?

• Experienced Healthcare Professionals: All tests are supervised and validated by highly qualified clinical pathologists and laboratory technologists.
• Patient-Focused Care: Dedicated to providing a compassionate, seamless, and stress-free diagnostic experience for every patient.
• Quality Diagnostic Services: Adherence to strict international quality control standards and participation in external quality assurance programs.
• Professional Reporting: Clear, comprehensive, and easy-to-read diagnostic reports that facilitate precise clinical decision-making.
• Modern Diagnostic Approach: Utilization of advanced, fully automated clinical chemistry analyzers for maximum testing accuracy.
• Comfortable Environment: Modern, hygienic, and well-maintained collection centers designed with patient comfort in mind.
• Convenient Location: An extensive network of diagnostic centers and collection points across major cities in Pakistan.
• Commitment to Accurate Diagnosis: Reliable and rapid turnaround times to ensure timely medical intervention and peace of mind.